Menu Search
Equities

iRhythm Technologies Inc

IRTC:NSQ

iRhythm Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)87.20
  • Today's Change-1.73 / -1.95%
  • Shares traded334.43k
  • 1 Year change+20.39%
  • Beta1.2632
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year iRhythm Technologies Inc had net income fall 6.24% from a loss of 116.16m to a larger loss of 123.41m despite a 19.90% increase in revenues from 410.92m to 492.68m. An increase in the cost of goods sold as a percentage of sales from 31.46% to 32.65% was a component in the falling net income despite rising revenues.
Gross margin67.83%
Net profit margin-26.90%
Operating margin-28.25%
Return on assets-22.33%
Return on equity-103.34%
Return on investment-26.27%
More ▼

Cash flow in USDView more

In 2023, cash reserves at iRhythm Technologies Inc fell by 42.66m. Cash Flow from Financing totalled 8.82m or 1.79% of revenues. In addition the company used 50.10m for operations while cash used for investing totalled 1.21m.
Cash flow per share-4.20
Price/Cash flow per share--
Book value per share2.29
Tangible book value per share2.27
More ▼

Balance sheet in USDView more

iRhythm Technologies Inc has a Debt to Total Capital ratio of 90.00%, a higher figure than the previous year's 15.90%.
Current ratio6.27
Quick ratio6.12
Total debt/total equity9.00
Total debt/total capital0.90
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.